Daily as of 3 Nov 16:00 ET
- Price
- below both $14.29 vs 50 $16.95 / 200 $20.17
- Projection
- No cross projected
- Test
- No active test
- Last cross
- 💀Death cross 4 Aug 2026 · projected 10 bars out · tested 5 bars
SNDX | Syndax PharmaceuticalsNASDAQHealthcareCommon stock golden cross and death cross projections, cross tests and history
$14.29
+$1.19 (+9.08%)
Syndax Pharmaceuticals (SNDX) is a NASDAQ-listed common stock that Cruxta has tracked for 50/200 crosses since 2017.
The 50 SMA has sat below the 200 on the daily since Aug 2026, with no cross projected inside the 30 bars Cruxta tracks. Price sits below the 50 and the 200 on the daily, the weekly and the 4-hour.
Timeframe summary
Weekly as of 30 Oct 16:00 ET
- Price
- below both $13.65 vs 50 $20.15 / 200 $18.51
- Projection
- 💀Death cross estimated 15+ weeks out
- Test
- No active test
- Last cross
- 🟨Golden cross week of 6 Jul 2026 · projected 30 bars out · tested 3 bars
4-hour as of 3 Nov 16:00 ET
- Price
- below both $14.29 vs 50 $14.96 / 200 $18.86
- Projection
- No cross projected
- Test
- No active test
- Last cross
- 💀Death cross 13 Aug 2026 · projected 27 bars out
Cross history
| Crossed | Direction | Timeframe | Projected | Cross test |
|---|---|---|---|---|
| 13 Aug 2026 | 💀Death | 4-hour | 27 bars out | Not tested |
| 4 Aug 2026 | 💀Death flat | daily | 10 bars out | 5 bar cross test |
| 22 Jul 2026 | 🟨Golden | 4-hour | 29 bars out | 4 bar cross test |
| week of 6 Jul 2026 | 🟨Golden moderate | weekly | 30 bars out | 3 bar cross test |
| 14 May 2026 | 💀Death | 4-hour | 18 bars out | Not tested |
About SNDX
ExchangeNASDAQ
InstrumentCommon stock
Median $ volume, 60 d$28.1M
4-hour coverageYes, since Oct 2025
History on recordSince 2017
SectorHealthcare
Cap bandsmall